The efficacy of low-dose intranasal scopolamine for motion sickness.

Introduction: Scopolamine is an effective motion sickness prophylactic, but oral and transdermal formulations are slowly absorbed. To enhance absorption and potentially efficacy, an intranasal formulation of scopolamine (INSCOP) was tested.

Method: There were 16 motion sickness susceptible subjects with an average age of 23.